Liver-focused treatment for diabetic eye swelling
Treatments studied
Part of Eyes & vision, Hormones & metabolism clinical trials.
This trial tests whether a substance called tauroursodeoxycholate (TUDCA) or a traditional Chinese medicine can help reduce swelling in the back of the eye caused by diabetes. It is for people with diabetic retinopathy and diabetic macular edema who have not had recent eye surgeries or changes in blood sugar or blood pressure control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 89 years old.
- You have diabetes-related swelling in the central part of the retina (macula) and your vision is between 20/32 and 20/200.
- You have not had trouble controlling your diabetes or blood pressure in the last 3 months.
- You have not had any eye surgery in the last 6 months (or laser eye surgery in the last 3 months).
- You are not currently taking anti-inflammatory medications or certain cholesterol-lowering drugs (like atorvastatin).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called CU06-1004 for people with diabetic macular edema (swelling in the center of the retina caused by diabetes). It aims to see if the drug can improve vision and reduce swelling.
This study compares two injectable medicines (BAT5906 and Lucentis) to treat diabetic macular edema—swelling in the back of the eye that blurs vision. Both drugs block a protein that causes abnormal blood vessel leakage, and this trial will show which works better.
This trial tests a new eye drop or injection called ENN0403 for people with diabetic macular edema (swelling in the back of the eye due to diabetes). The goal is to see if it can improve vision and reduce swelling.
This study tests whether Zhuochuming®-3T&E, a new eye medicine, can reduce swelling in the macula (the center of the retina responsible for sharp vision) in people with diabetes who have never been treated for this condition before. The goal is to improve vision and prevent further vision loss.
This trial tests if combining a steroid implant (dexamethasone) with an anti-VEGF injection (aflibercept) works better than aflibercept alone for people with diabetic macular edema caused by inflammation. It aims to find the best first treatment for improving vision and reducing swelling.
This study tests whether an octreotide nasal spray can reduce swelling in the center of the retina caused by diabetic macular edema. It's an early-phase trial for people with diabetes who have not had recent eye treatments or certain medications.
Hear when a new Diabetic Macular Edema (DME) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.